Among them: Will insurers broadly cover GLP-1s for obesity? JPM thinks studies showing that these medicines can lower the risk of heart problems, kidney problems, and other health issues in people who are very overweight and have other diseases should advance payer decisions on broadly reimbursing obesity
Like so many biohackers before me, I began by doing my own research on Reddit and stumbled upon a thread recommending a supposedly Toronto-based company called Growth Guys. The site claimed BPC-157 could help activate cells involved in tissue repair, including muscles, tendons, ligaments and the gastrointestinal tract, stimulating the synthesis of growth factors, and inhibiting inflammation. It featured a third-party lab report, claiming the compound was 99.88 per cent pure
[6] One researcher summarized it bluntly: It is not possible to increase circulating glutathione to a clinically beneficial extent by the oral administration of a single dose of glutathione. [5] So why do people keep buying these supplements
New AI-based research reveals GLP-1 side effects missed in clinical trials New AI-based research showed there may be some side effects from taking a GLP-1 that are being missed in clinical trials
Stimulation of GH with human GRF1-44, GRF1-40, and GRF1-29 in normal subjects
Crystals, 11 (5), 505
